SMAD2 and lung carcinoma: We identified JMJD3 as a strong enhancer of TGF-β signaling in Ras-activated lung cancer cells and showed that it induces syntenin to promote the activation of Smad2/3, thereby promoting tumorigenic TGF-β function in EMT and metastasis.